{"nct_id":"NCT03401788","title":"A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-11","start_date":"2018-05-02","start_date_type":"ACTUAL","primary_completion_date":"2026-03-29","primary_completion_date_type":"ESTIMATED","completion_date":"2026-03-29","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}